Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen, Inc. (AMGN) American Heart Association (AHA) Scientific Sessions 2022 Transcript
08:52pm, Saturday, 12'th Nov 2022
Amgen, Inc. (NASDAQ:AMGN ) American Heart Association (AHA) Scientific Sessions 2022 November 8, 2022 4:30 AM ET Company Participants David Reese - EVP, Research & Development Arvind Sood - VP, IR Nar
2 Ultra-Safe Passive Income Stocks to Buy Right Now
01:15pm, Thursday, 10'th Nov 2022 The Motley Fool
These two top biopharma stocks are crushing the 2022 bear market.
2 Ultra-Safe Passive Income Stocks to Buy Right Now
08:15am, Thursday, 10'th Nov 2022
These two top biopharma stocks are crushing the 2022 bear market.
Biotech Stock Roundup: REGN, AMGN, MRNA's Q3 Earnings, VERV Down on Update
05:35pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Earnings updates from REGN and MRNA are the key highlights from the biotech sector during the past week.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
02:00pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
How Are Biotech ETFs Reacting to Q3 Earnings Releases?
01:00pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Biotech earnings have come in upbeat in the third quarter.
Should You Invest in the iShares Biotechnology ETF (IBB)?
11:20am, Wednesday, 09'th Nov 2022 Zacks Investment Research
Sector ETF report for IBB
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Wednesday, 09'th Nov 2022
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Markets Up on Election Day; DIS, AFRM Report, Sell Off
10:58pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Perhaps well have a clear picture of midterm results prior to Thursday morning's CPI report, or perhaps we won't.
Markets Up on Election Day; DIS, AFRM Report, Sell Off
07:33pm, Tuesday, 08'th Nov 2022
Perhaps well have a clear picture of midterm results prior to Thursday morning's CPI report, or perhaps we won't.
Ligand (LGND) Beats on Q3 Earnings, Lags Sales, Ups '22 Outlook
04:17pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Ligand (LGND) reports mixed third-quarter 2022 numbers, beating sales estimates but missing out on earnings. Share price rises as management lifts financial guidance for the year.
AMGEN ANNOUNCES WEBCAST OF 2022 CREDIT SUISSE GLOBAL HEALTHCARE CONFERENCE
04:00pm, Friday, 04'th Nov 2022
THOUSAND OAKS, Calif. , Nov. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Credit Suisse 31st Annual Global Healthcare Conference at 3:50 p.m.
Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View
12:03pm, Friday, 04'th Nov 2022
Amgen (AMGN) beats Q3 estimates for earnings and sales. It tightens previously issued revenue and adjusted earnings guidance ranges.
Amgen Inc. (AMGN) Q3 2022 Earnings Call Transcript
09:12pm, Thursday, 03'rd Nov 2022
Amgen Inc. (NASDAQ:AMGN ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO Murdo Gordon - EVP,
Amgen (AMGN) Surpasses Q3 Earnings and Revenue Estimates
06:52pm, Thursday, 03'rd Nov 2022
Amgen (AMGN) delivered earnings and revenue surprises of 6.09% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
